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Research
Exposure to particulate air pollution has been 
associated with cardiovascular morbidity and 
mortality in numerous epidemiologic studies 
(Brook 2008; Pope et al. 2004). Black carbon 
(BC), a combustion by-product, is a widely 
used marker of traffic pollution and has been 
linked to cardiac and ventricular arrhythmias 
(Rich et al. 2005), ST-segment depression 
(Gold et al. 2000), decreased flow-mediated 
vascular reactivity (O’Neill et al. 2005), lowered 
heart rate variability (Schwartz et al. 2005), and 
increased cardiovascular mortality (Maynard 
et al. 2007). Growing evidence suggests that 
traffic-related pollution, including BC, may 
be driving the cardiotoxic effects observed in 
response to air pollution exposures (Hoffmann 
et al. 2007). A few recent studies have exam-
ined associations between particles and blood 
pressure (BP), and although positive associa-
tions have been observed (Auchincloss et al. 
2008; Ibald-Mulli et al. 2001; Zanobetti et al. 
2004), both inverse (Harrabi et al. 2006) and 
null (Jansen et al. 2005; Madsen and Nafstad 
2006) associations have also been reported.
MicroRNAs (miRNAs) are small, non-
coding RNAs that repress or inhibit gene 
expression by targeting messenger RNA 
(mRNA) (Mattick and Makunin 2006; Zhang 
2008). Evidence suggests that miRNAs affect 
pathogenic pathways including angiogene-
sis (Suarez and Sessa 2009), redox signaling 
(Brewer and Shah 2009; Urbich et al. 2008), 
and stress response (van Rooij et al. 2007). 
Much of the existing miRNA-related litera-
ture has focused on cancer outcomes (Esquela-
Kerscher and Slack 2006; Hu et al. 2008, 
2009; Luthra et al. 2008; Yang et al. 2008). 
However, there is growing evidence that the 
dysregulation of cell-signaling pathways asso-
ciated with miRNA is a key factor affecting 
heart disease (Chen et al. 2008; Cheng et al. 
2007; Divakaran and Mann 2008; Ikeda et al. 
2007; Zhang 2008). Additionally, studies in 
controlled environments have demonstrated 
cardiovascular effects due to loss of function of 
miRNA processing genes (Asada et al. 2008; 
da Costa Martins et al. 2008; Suarez et al. 
2007). For the current study, we genotyped 
participants for potentially functional single 
nucleotide polymorphisms (SNPs) involved 
in the processing and formation of miRNAs. 
We then investigated the association between 
air pollution and BP as well as potential dif-
ferences in susceptibility by SNP carrier status. 
We hypothesized that polymorphisms in genes 
that regulate miRNA processing could modify 
effects of BC on BP, a marker of autonomic 
function and cardiovascular health.
Materials and Methods
Study population. Our study participants were 
members of the Veterans Affairs Normative 
Aging Study (NAS). This is an ongoing lon-
gitudinal study of aging established in 1963, 
details of which have been published pre-
viously (Bell et al. 1966). Briefly, the NAS 
began as a closed cohort of 2,280 male vol-
unteers from the greater Boston area, 21–80 
years of age at entry, who enrolled after an 
initial health screening determined that they 
were free of known chronic medical condi-
tions. All participants provided informed con-
sent. Collection of blood samples for genetic 
analysis began in the late 1990s; 942 par-
ticipants were still actively participating and 
provided BP and blood samples for some or 
all miRNA-related SNPs, which were success-
fully genotyped. Participants were reevaluated 
every 3–5 years using detailed on-site physical 
examinations and questionnaires.
Physical parameters and medical history. 
Study center visits occurred after an overnight 
fast and abstention from smoking. Physical 
examination included measurement of height 
and weight, with body mass index (BMI) cal-
culated as weight (kilograms)/height (meters 
squared). Questionnaires evaluated lifestyle 
factors and medication use. Type 2 diabetes 
was classified based on physician’s diagnosis 
or fasting blood glucose > 126 mg/dL.
BP measurements. At each clinical visit, 
a physician measured BP using a standard 
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Ba c k g r o u n d: Black carbon (BC) is a marker of traffic pollution that has been associated with 
blood pressure (BP), but findings have been inconsistent. MicroRNAs (miRNAs) are emerging as 
key regulators of gene expression, but whether polymorphisms in genes involved in processing of 
miRNAs to maturity influence susceptibility to BC has not been elucidated.
oBjectives: We investigated the association between BC and BP, as well as potential effect modifi-
cation by single nucleotide polymorphisms (SNPs) in miRNA processing genes.
Me t h o d s : Repeated measures analyses were performed using data from the VA Normative Aging 
Study. Complete covariate data were available for 789 participants with one to six study visits between 
1995 and 2008. In models of systolic and diastolic BP, we examined SNP-by-BC interactions with 
19 miRNA-related variants under recessive models of inheritance. Mixed-effects models were adjusted 
for potential confounders including clinical characteristics, lifestyle, and meteorologic factors.
re s u l t s: A 1-SD increase in BC (0.415 µg/m3) was associated with 3.04 mmHg higher systolic 
(95% confidence interval (CI), 2.29–3.79) and 2.28 mmHg higher diastolic BP (95% CI, 1.88–
2.67). Interactions modifying BC associations were observed with SNPs in the DICER, GEMIN4, 
and DiGeorge critical region-8 (DGCR8) genes, and in GEMIN3 and GEMIN4, predicting diastolic 
and systolic BP, respectively.
co n c l u s i o n s: We observed evidence of effect modification of the association between BP and 
7-day BC moving averages by SNPs associated with miRNA processing. Although the mechanisms 
underlying these associations are not well understood, they suggest a role for miRNA genesis and 
processing in influencing BC effects.
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mercury sphygmomanometer with a 14-cm 
cuff. Systolic BP (SBP) and fifth-phase dia-
stolic BP (DBP) were measured in each arm 
to the nearest 2 mmHg while the partici-
pant was seated. The means of the right and 
left arm measurements were used as the BP 
measurement of each participant for analyti-
cal purposes. Although there was no specific 
rest period prior to measurement of BP, SBP 
and DBP were measured immediately after a 
complete patient history was taken with the 
subject seated.
SNP selection and genotyping. SNPs 
were selected based on previously published 
work investigating associations between genes 
involved in miRNA processing and disease 
(Horikawa et al. 2008; Yang et al. 2008). These 
SNPs were chosen because of overlap in path-
ways involved in cancer processes related to 
autonomic function through cell signaling, 
apoptosis, angiogenesis, and inflammation. 
Genotyping was performed using multiplex 
polymerase chain reaction assays designed 
with Sequenom SpectroDESIGNER software 
(Sequenom, Inc., San Diego, CA). The exten-
sion product was then spotted onto a 384-well 
spectroCHIP before analysis in the MALDI-
TOF mass spectrometer (Sequenom, Inc.). 
Duplication was performed on 5% of the sam-
ples. The 24 SNPs analyzed for this study were 
all successfully genotyped. After genotyping, we 
excluded those SNPs for which fewer than 10 
participants were homozygous variant carriers 
[rg1106042 in HIWI, rs3742330 in DICER, 
rs417309 in DiGeorge critical region-8 
(DGCR8), rs636832 in Argonaute 1 (AGO1)] 
and also those with a Hardy–Weinberg p-value 
< 0.05 (rs10719 in DROSHA), leaving a total 
of 19 SNPs in 10 genes.
BC and meteorologic measurements. 
Continuous BC was measured at a Harvard 
School of Public Health monitoring site 
located at Countway Library (10 Shattuck 
Street, Boston, MA, USA), 1 km from the 
clinical examination site, and was averaged 
by hour before BP measurement using an 
aethalometer (Magee Scientific, Berkeley, CA, 
USA). We obtained temperature and relative 
humidity measures from the Boston airport 
weather station.
Statistical methods. Because repeated meas-
ures of BP were available for many of these 
study participants with both BC measurements 
and genotyping, we were able to obtain greater 
power by using multiple measures. We evalu-
ated SBP and DBP as dependent variables and 
analyzed their associations with BC in linear 
mixed-effects models. Previous studies have 
suggested that longer averaging times are more 
relevant to the associations between particles 
and BP (Zanobetti et al. 2004), and recent sen-
sitivity analysis within the NAS found 7-day 
moving averages as being most strongly associ-
ated with BP outcomes for short-term time 
windows (1 hr to 1 week) (Mordukhovich 
et al. 2009). Therefore, we used 7-day mov-
ing averages of ambient BC concentrations 
matched on the time of BP measurement for 
each participant, and we evaluated SBP and 
DBP as dependent variables.
We examined associations between BP 
and BC using two different approaches to 
address potential confounding. In model 1, 
we adjusted for age, BMI, BC, and apparent 
temperature (a marker of perceived tempera-
ture) as continuous variables as well as smoking 
status (never, current, former) and season of 
clinical visit (spring: March–May; summer: 
June–August; fall: September–November; 
winter: December–February). In model 2, we 
adjusted for covariates included in model 1 as 
well as blood urea nitrate, pulse, and median 
income treated as continuous variables in addi-
tion to education (≤ 12 years, 13–16 years, 
and > 16 years), alpha blocker, beta blocker, 
calcium channel blocker, angiotensin recep-
tor blocker, angiotensin-converting enzyme 
(ACE) inhibitor, diuretic use, two or more 
alcoholic drinks per day, and diabetes diagno-
sis. We chose to examine recessive models of 
inheritance only (rather than dominant and 
additive) to limit the number of associations 
tested. Covariates from model 2 were selected 
a priori to be included in the regression mod-
els, regardless of statistical significance. We 
then examined the associations between the 
19 SNPs in miRNA processing genes as well 
as SNP-by-BC cross-product terms to assess 
interactions. The default α level was defined as 
p = 0.05.
We performed sensitivity analyses to 
determine whether our results were robust to 
changes in the covariates adjusted for in the 
models and also whether there were significant 
effects due to missing data. To address attri-
tion in the study, we used inverse probability 
weighting to determine whether reweighting 
these observations with only one or two 
repeated measures significantly changed our 
results (Hernan et al. 2006). This was done 
by modeling the probability of having only 
one measurement or only two measurements 
using the covariates described in model 2 and 
treating those participants with three or more 
visits as the reference group. We then used the 
inverse of the predicted values as the weights. 
We also examined associations adjusting only 
for covariates selected in model 1 to determine 
whether the significance and or magnitude of 
our adjusted results changed. Linkage disequi-
librium (LD) between SNPs in the same gene 
that met the significance criterion were assessed 
using the LDPlotter tool (Innate Immunity in 
Heart Lung and Blood Disease; http://www.
pharmgat.org/IIPGA2/Bioinformatics/).
Results
Of the 2,280 men who originally entered 
the cohort in 1963, complete covariate data 
were available on participants who took part 
in one to six examinations during the study 
period. Because the NAS comprises over 95% 
white participants, we restricted our analy-
sis to white individuals based on self-report. 
There were 942 participants with some or all 
microRNA-processing genotyping data and 
BP measurements. Of these, BC data were 
available for 799 participants who reside in 
Massachusetts. All visits occurred between 
1995, when pollutant monitoring began, and 
2008. Our full models (model 2) include 
data from the 789 participants with complete 
  covariate data and some or all genotyping 
data. In this group, 645 (82%) participants 
had at least two study visits from 1995 to 
2008; 475 (60%) had three or more visits. 
Our study population was composed entirely 
of males, most of whom were former cigarette 
Table 1. Descriptive statistics at baseline for par-
ticipants included in analysis (n = 789).a 
Study characteristic Value
BP measurements
SBP (mmHg) 132.0 ± 18.4
DBP (mmHg) 76.8 ± 10.9
Clinical measures
Age at visit (years) 72.3 ± 7.5
BMI (kg/m2 ) 28.0 ± 4.1
Pulse (beats/min) 71.1 ± 8.1
Hypertension diagnosis 542 (81.8)
Hypertension medication use 478 (72.1)
Two or more drinks per day 199 (25.2)
Diabetesb 182 (23.1)
Education (years)
≤ 12 280 (35.5)
13–16 372 (47.2)
> 16 137 (17.3)
Smoking status
Never 237 (30.0)
Current 47 (6.0)
Former 505 (64.0)
Air pollution and weather data
Seven-day moving average BC (µg/m3) 0.98 ± 0.415
Values are mean ± SD or no. (%).
aA total of 2,349 observations (one to six study visits) 
from 789 NAS participants were included in these analy-
ses. bDiabetes was classified as physician-diagnosed 
diabetes mellitus or fasting blood glucose > 126 mg/dL.
Table 2. Linear mixed-effects models estimat-
ing the change in BP associated with a 1-SD 
  increasea in BC.b
Model 1c  
mmHg (95% CI)
Model 2d  
mmHg (95% CI)
SBP 3.52 (2.77–4.26) 3.04 (2.29–3.79)
DBP 2.72 (2.31–3.12) 2.28 (1.88–2.67)
aCorresponding to a 0.415-µg/m3 increase in 7-day aver-
age BC concentrations. bA total of 2,349 observations 
from 789 NAS participants were included in these analy-
ses. cModel 1 was adjusted for age, BMI, smoking status, 
season, 7-day moving average of BC, and 7-day moving 
average of apparent temperature. dModel 2 was adjusted 
for education, blood urea nitrate, age, BMI, pulse, smok-
ing status, pack-years, median income, apparent tem-
perature, alpha blocker use, beta blocker use, calcium 
channel blocker use, angiotensin receptor blocker use, 
ACE inhibitor use, diuretics, season, two or more drinks 
per day, and diabetes diagnosis.Black carbon, blood pressure, and miRNA-related SNPs
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smokers (Table 1). The mean age (± SD) of 
study participants was 72.3 ± 7.5 years and 
mean BMI was 28.0 ± 4.1 kg/m2. Average 
SBP and DBP were 132 ± 18.4 mmHg and 
76.8 ± 10.9 mmHg, respectively. We evaluated 
the association of SBP and DBP with ambient 
BC and expressed the results as the mmHg 
change associated with a 1-SD increase in BC 
(equivalent to 0.415 µg/m3) (Table 2). In our 
fully adjusted models (model 2), we found 
that a 1-SD increase in BC concentration 
was associated with 3.04-mmHg higher SBP 
(95% CI, 2.29–3.79; p = 0.003) and a 2.28-
mmHg higher DBP (95% CI, 1.88–2.67; 
p < 0.001). These associations were attenuated 
compared with our model 1 analyses, which 
were adjusted for a subset of potential con-
founders. In model 1 analyses, we observed 
that a 1-SD change in BC was associated 
with 3.52-mmHg (95% CI, 2.77–4.26) and 
2.72-mmHg (95% CI, 2.31–3.12) changes in 
SBP and DBP, respectively.
The complete list of the 19 SNPs ana-
lyzed is described in Table 3. We genotyped 
24 SNPs and excluded those SNPs that, in 
fewer than 10 study participants, were 
homozygous carriers of the variant allele 
(rg1106042 in HIWI, rs3742330 in DICER, 
rs417309 in DGCR8, rs636832 in AGO1) 
and those in which Hardy–Weinberg equilib-
rium was not met at the 0.05 level (rs10719 
in DROSHA), leaving a total of 19 SNPs in 
10 genes. First, we examined the main effects 
of the SNPs of interest within this popula-
tion. In our fully adjusted models, none of 
these SNPs were associated with BP at the 
0.05 level. We examined BC-by-SNP inter-
actions, and results are reported in Table 4. 
In models of SBP, interactions with BC were 
observed for two SNPs. For homozygous vari-
ant carriers of rs197414, a 1-SD change in 
BC was associated with 9.82-mmHg lower 
DBP (95% CI, –18.68 to –0.95), whereas in 
wild-type individuals and heterozygous car-
riers, we observed a 3.07-mmHg increase in 
BP (95% CI, 2.32–3.82); however, there were 
only 10 homozygous carriers of this variant, 
and the CI of these carriers is very wide. We 
also observed 5.58-mmHg higher BP (95% 
CI, 3.01–8.14) among GEMIN4 rs1062923 
homozygous recessive carriers in response to a 
1-SD change in BC, but only 2.87 (95% CI, 
2.10–3.65) in heterozygotes and homo  zygous 
wild-type carriers. Because this SNP had a 
Hardy–Weinberg p-value of 0.05, we approach 
interpretation of these results with caution.
We observed statistically significant inter-
actions for four SNP-by-BC inter  actions pre-
dicting DBP. In all of these analyses, smaller 
changes in BP were observed for carriers of the 
homozygous variant genotype. A 1-SD change 
in BC was associated with 1.48-mmHg higher 
DBP (95% CI, 0.78–2.18) for homozygous 
variant carriers and 2.57 mmHg (95% CI, 
2.12– 3.02) in others. The rs13078 DICER 
SNP was associated with 0.13-mmHg higher 
Table 3. SNPs in miRNA processing genes included in analysis.
Genea RS number SNP position Alleles Role Amino acid change MAF (%)
Gem-associated protein 3 rs197414 chr1:112110646 C/A Coding exon Arginine/serine 0.12
(GEMIN3) (DDX20) rs197388 chr1:112099005 T/A Promoter 0.18
rs197412 chr1:112110476 T/C Coding exon Isoleucine/threonine 0.38
AGO1 (EIF2C1) rs595961 chr1:36140367  A/G Intron 0.15
DROSHA (RNASEN) rs6877842 chr5:31568395 G/C Promoter 0.18
Exportin 5 (XPO5) rs11077 chr6:43598925 C/A 3´ UTR 0.40
AGO2 (EIF2C2) rs4961280 chr8:141716596  C/A Promoter 0.18
Tar-RNA binding protein 2 (TARBP) rs784567b chr12:52180732 C/T Promoter 0.49
DICER (DICER1) rs13078 chr14:94626500 T/A 3´ UTR 0.18
Gem-associated protein 4 (GEMIN4) rs7813 chr17:594936 T/C Coding exon Cysteine/arginine  0.43
rs1062923c chr17:595817 T/C Coding exon Isoleucine/threonine 0.19
rs3744741 chr17:595982 C/T Coding exon Arginine/glutamine 0.11
rs4968104 chr17:596255 T/A Coding exon Valine/glutamic acid 0.27
rs910925 chr17:596297 G/C Coding exon Glycine/alanine 0.42
rs2740348  chr17:596685 G/C Coding exon  Glutamic acid/glutamine 0.15
rs910924 chr17:602670 C/T Promoter 0.27
DiGeorge syndrome critical region gene 8 (DGCR8) rs3757 chr22:18479331 G/A 3´ UTR 0.25
rs1640299  chr22:18478359 G/T 3´ UTR  0.48
Ras-related nuclear protein (RAN) rs14035 chr12:129927194 C/T 3´ UTR 0.28
Abbreviations: HWE, Hardy–Weinberg equilibrium; MAF, minor allele frequency; RS, reference SNP.
aGene name (abbreviation), official gene symbol. bHWE p = 0.08. cHWE p = 0.05. 
Table 4. Effect modification of the association between a 1-SDa increase in BC concentrations and BP by 
gene variants related to miRNA processing under recessive models.b
Sensitivity analyses
Results  
Δ mmHg (95% CI)
Model 2 
p-interactionc
Model 1 
p-interaction
IPW  
p-interactiond
DBP
DGCR8 rs1640299
Wild-type and heterozygotes 590 2.57 (2.12 to 3.02) 0.006 0.002 0.004
Homozygous carriers 189 1.48 (0.78–2.18)
DICER rs13078
Wild-type and heterozygotes 738 2.32 (1.91 to 2.72) 0.017 0.03 0.008
Homozygous carriers 25 0.13 (–1.65 to 1.91)
GEMIN4 rs7813
Wild-type and heterozygotes 638 2.44 (2.00 to 2.87) 0.02 0.04 0.006
Homozygous carriers 136 1.40 (0.60 to 2.21)
GEMIN4 rs910925
Wild-type and heterozygotes 647 2.44 (2.02 to 2.87) 0.024 0.04 0.006
Homozygous carriers 134 1.43 (0.61 to 2.25)
SBP
GEMIN3 rs197414
Wild-type and heterozygotes 769 3.07 (2.32 to 3.82) 0.005 0.01 0.01
Homozygous carriers 10 –9.82 (–18.68 to –0.95)
GEMIN4 rs1062923
Wild-type and heterozygotes 739 2.87 (2.10 to 3.65) 0.045 0.04 0.027
Homozygous carriers 37 5.58 (3.01 to 8.14)
aA 1-SD increment in BC concentration is equal to 0.415 µg/m3. bAdjusted for age (years), BMI, cigarette smoking status 
(never, current, former), pack-years smoked, blood urea nitrate, type 2 diabetes diagnosis, two or more alcoholic drinks 
per day, and current antihypertensive medication use (including angiotensin II receptor-, alpha-adrenoceptor, beta- or 
calcium channel blockers, diuretics, or ACE inhibitors) as well as apparent temperature, and season of clinical visit 
(spring: March–May; summer: June–August; autumn: September–November; winter: December–February). cTwo-sided 
p-value for interaction from SNP-by-BC coefficient. dp-Value for interaction from SNP-by-BC coefficient for sensitivity 
analysis using IPW.Wilker et al.
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BP in carriers of the homozygous variant 
(95% CI, –1.65 to 1.91) and 2.32 (95% 
CI, 1.91–2.72) in others. Under a reces-
sive model, homozygous carriers of the vari-
ant alleles of rs7813 and rs910925, both in 
GEMIN4, were both associated with lower 
BP in response to a 1-SD increase in BC com-
pared with others. Both these SNPs produced 
very similar magnitudes of effect and were 
found to be in high LD (r2 = 0.9). As a sen-
sitivity analysis, we also investigated whether 
there were significant associations in models 
adjusted only for model 1 variables, and the 
same SNPs achieved significant results. We 
also tested our associations using inverse prob-
ability weighting (IPW) to address attrition 
and found that our most significant results for 
both SBP and DBP became more significant, 
although changes associated with the IPW 
analysis were modest. We report the model 1 
p-values and IPW p-values for sensitivity addi-
tionally in Table 4.
Discussion
We observed that BC concentration averaged 
over the 7 days preceding each study center 
visit was positively associated with SBP and 
DBP in a cohort of elderly men. Furthermore, 
SNPs in miRNA processing genes modified the 
BC associations with BP that we observed. Our 
analysis focused on potentially functional SNPs 
located in genes involved in the processing of 
miRNAs. To our knowledge, this is the first 
study to investigate the role of polymorphisms 
in miRNA processing genes to be identified as 
effect modifiers of an association between air 
pollution and cardiovascular response.
We selected these SNPs because of their 
involvement in the biogenesis and processing 
of miRNA. The transcription and process-
ing of miRNAs has been described in detail 
elsewhere (Bartel 2004). Briefly, miRNAs are 
processed in a multistep pathway (Figure 1). 
First, long primary transcripts coded within 
the introns of protein-coding genes are tran-
scribed into primary miRNAs (pri-  miRNAs) 
approximately 100 nucleotides (nt) in 
length. Through a series of steps mediated 
by DROSHA and DGCR8, the pre-miRNA 
stem-loop (approximately 70–100 nt) is 
formed. After export from the nucleus via the 
RAN-GTP complex and XPO5, these pre-
miRNAs undergo modification by DICER 
within the cytoplasm to generate an ~ 22-nt 
duplex from the loop complex, which com-
prises miRNA and its complement. AGO2, 
GEMIN3, and GEMIN4 then interact with 
miRNA to form a ribonucleoprotein, which 
guides the miRNA into the RNA-induced 
silencing complex (RISC), where the miRNA 
strand anneals to the 3´ untranslated regions 
(UTRs) of target mRNAs, promoting transla-
tional repression or mRNA degradation. More 
than 700 human miRNA have been identi-
fied in the miRBase Registry (http://microrna.
sanger.ac.uk/) (Griffiths-Jones et al. 2008).
It has been shown that miRNAs, which 
are generally associated with silencing or sup-
pression of target gene transcripts (negative 
regulation), may become activators of gene 
expression during stress (Rocha 2007; Yang 
and Paschen 2008). Animal studies have 
also shown that miRNA expression is down-
regulated in lungs of rats exposed to cigarette 
smoke, which is consistent with the hypothesis 
that alterations of the miRNA control mecha-
nism can occur even after relatively short peri-
ods of exposure (Izzotti et al. 2009). Other 
forms of epigenetic regulation, such as DNA 
methylation, have been associated with expo-
sure to traffic particles (Baccarelli et al. 2009). 
Recently, miRNA processing genes, such as 
DICER, have been associated with endothelial 
function and angiogenesis (Suarez et al. 2007).
None of the interactions identified were 
significantly predictive of both SBP and DBP. 
Although BC interactions with SNPs in 
DGCR8, DICER, and GEMIN4 were observed 
in models of DBP, only interactions with sin-
gle SNPs in GEMIN3 and GEMIN4 were 
predictive of SBP. The DICER and DGCR8 
SNPs for which we observed interactions pre-
dicting DBP are both located within 3´ UTRs. 
These regions are not translated directly into 
the protein; however, they are thought to play 
a role in mRNA stability. Additionally, these 
polymorphisms may affect miRNA binding 
to the 3´ UTR of target mRNAs. Previously, 
DICER knockdown increased activation of 
the endothelial nitric oxide synthase pathway 
(Suarez et al. 2007). DICER is thought to be 
more generally involved in miRNA process-
ing, whereas DGCR8 is thought to be more 
specific to particular miRNAs (Han et al. 
2006). DGCR8 is required for the maturation 
of miRNA primary transcripts at the initial 
stages. A recent study found that deletion of 
DGCR8 in cardiomyocytes leads to left ven-
tricular malfunction progressing to a dilated 
cardiomyopathy and premature lethality (Rao 
et al. 2009), which suggests a central role of 
this gene in cardiovascular function. Lack of 
DICER activity in knockout studies has been 
suggested to be associated with defective blood 
vessel formation (Bernstein et al. 2003; Yang 
et al. 2005). However, no associations predict-
ing SBP have been observed for the particular 
SNPs that we observed interacting with BC. 
In our analyses, we found that BC interac-
tions with SNPs in GEMIN4 were associated 
with SBP and DBP. Interactions with one 
SNP in GEMIN3, rs197414, was also associ-
ated with SBP. These genes code for proteins 
associated with the survival motor neuron 
Figure 1. Major steps in miRNA processing. Long primary transcripts coded within the introns of protein-
coding genes are transcribed into primary miRNAs (pri-miRNAs). Then DROSHA and the DGCR8 complex 
mediate the formation of the pre-miRNA stem-loop. After export from the nucleus via the RAN-GTP com-
plex and Exportin5, these pre-miRNAs undergo modification by DICER within the cytoplasm to generate an 
~ 22-nt duplex from the loop complex, which comprises the miRNA and its complement. AGO2, GEMIN3, 
and GEMIN4 then interact with miRNA to form a ribonucleoprotein that guides the miRNA into the RISC, 
where the miRNA strand anneals to the 3´ UTRs of target mRNAs, promoting translational repression or 
mRNA degradation. 
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(SMN) complex. GEMIN3 is a DEAD-box 
RNA helicase that binds directly with the 
SMN, and GEMIN4 is thought to play a role 
as cofactor in this response (Charroux et al. 
2000). Together, GEMIN3 and GEMIN4 
play a critical role in the processing of pre-
miRNA by introducing the miRNA precursor 
to the RISC (Murashov et al. 2007). Along 
with the AGO proteins, these genes form a 
complex with the miRNA to create a ribonu-
cleoprotein (Maniataki and Mourelatos 2005). 
Previously, the GEMIN3 SNP rs197414, for 
which we observed much lower BP among the 
few carriers, has been associated with higher 
bladder cancer rates (Yang et al. 2008). A 
study found that the GEMIN4 rs7813 vari-
ant was associated with in vitro hepatocellular 
carcinoma cell line growth inhibition com-
pared with the wild-type allele, suggesting that 
the amino acid change caused by this SNP 
might have physiologic significance (Wan 
et al. 2004).
Some mechanisms of BC effects may be 
different for SBP and DBP. For example, 
other studies have observed stronger associa-
tions between ambient pollutant exposures 
and DBP as opposed to SBP in human 
(Fakhri et al. 2009) and animal studies (Bartoli 
et al. 2009) in controlled environments. The 
mechanisms for these differences are not well 
understood. Systolic pressure rises with age; 
by contrast, diastolic pressure increases until 
around age 50 years and falls with increasing 
years (Burt et al. 1995). The role of SBP and 
DBP in predicting downstream health con-
sequences remains controversial. Some recent 
reports have suggested that SBP should be the 
primary risk factor reported in older individu-
als (Williams et al. 2008). However, within 
the Framingham Heart Study, isolated dia-
stolic hypertension was a cardiovascular risk 
factor (Franklin et al. 2009). Subjects with this 
condition were found to have about two times 
the cardiovascular risk with normal BP, and 
increased cardiovascular risk among subjects 
with isolated diastolic hypertension was con-
firmed in a multivariate-adjusted model.
We previously examined genetic polymor-
phisms in two specific pathways as modifi-
ers of the effects of air pollution within the 
NAS: oxidative stress and metal process-
ing. We chose these pathways because prior 
work suggested a) that particulate air pollu-
tion generated oxidative stress, and b) that 
the soluble metal component of particulate 
air pollution was responsible for part of the 
effect. Specifically, we examined SNPs in 
genes related to oxidative stress as modifiers of 
the effects of particles on heart rate variability 
(Chahine et al. 2007), on endothelial mark-
ers (Madrigano et al. 2009), and on plasma 
homocysteine (Ren et al. 2010). We have also 
examined them as modifiers of the effects of 
ozone on lung function (Alexeeff et al. 2007), 
and we have examined associations with SNPs 
in metal-processing genes and heart rate vari-
ability (Park et al. 2006; Ren et al. 2010). 
Recently, we reported that polymorphisms 
in oxidative defense genes did not signifi-
cantly modify the association of BC with BP, 
although there were trends in that direction 
(Mordukhovich et al. 2009). Taken together, 
these studies suggest that these pathways may 
be important for air pollution effects, although 
confirmation for other related outcomes and 
in other cohorts will be required.
In another recent paper, we demonstrated 
that BC exposure is associated with epigenetic 
changes—specifically, a reduction in LINE-1 
methylation (Baccarelli et al. 2009).   miRNAs 
are other important epigenetic mechanisms 
of gene expression control. Here we explored 
a novel pathway, polymorphisms in genes 
responsible for processing miRNAs, and 
found evidence for effect modification of BC 
on BP. Again, it will be important to deter-
mine whether these same polymorphisms 
modify effects on other end points and in 
other cohorts.
Although we believe our findings suggest 
altered susceptibility to BC exposures result-
ing from alterations in miRNA-processing 
related genotypes, we acknowledge that there 
are some limitations to our analysis. Despite 
these observations, we are not able to ascer-
tain whether the polymorphisms described 
here modify the associations with BC because 
they are more susceptible to downregulation 
or because their basal activity makes individu-
als more susceptible to downstream changes 
in biological function. It is possible that both 
mechanisms may be at work. Additionally, it 
is also possible that observed associations could 
be attributable to LD between the genotyped 
SNPs and some other causal variant. For each 
of the SNP-by-BC interactions examined, we 
limited our investigation to associations under 
a recessive model of inheritance to maximize 
power to detect interactions, and therefore we 
may have overlooked some true associations 
that would only be observed under other addi-
tive or dominant models of inheritance. On 
the other hand, we also face the problem of 
multiple comparisons, as we examined mul-
tiple SNPs in the miRNA pathway. We tested 
interactions with 19 SNPs in this study, and 
multiple testing is subject to false positives. 
However, whereas studies of large numbers 
of genes incorporate corrections for multiple 
testing, we did not test separate independent 
hypotheses. Rather, we tested consistency of 
the pattern of association examined and not 
just the significance of the most significant 
association for the 10 genes examined. 
We also acknowledge that there may be 
some misclassification of exposure in our 
analysis. Our study uses stationary measures of 
air pollution to represent personal exposures. 
Prior research indicates that when looking at 
longitudinal air pollution, most error is of the 
Berkson type. To the extent that this error is 
classical, simulation studies have shown that it 
is highly unlikely to bias away from the null 
even in the presence of covariates. This indi-
cates that this exposure misclassification may 
lead to an underestimation of the health effects 
of air pollution (Zeger et al. 2000). In addi-
tion, several studies, including one conducted 
in the greater Boston area, have found that lon-
gitudinal measures of ambient particulate con-
centrations are representative of longitudinal 
variation in personal exposures (Rojas-Bracho 
et al. 2000). BC concentrations are spatially 
heterogeneous because of the numerous local 
(mobile) sources. Therefore, measurement 
error in our BC exposure metric would likely 
attenuate the true association. Given that we 
found significant positive associations for BC, 
it is unlikely that this error would affect our 
conclusions. Our study population is homog-
enous, consisting entirely of elderly men, and 
we have restricted our analysis to white indi-
viduals. The median distance of the participant 
homes from the central site monitoring station 
was 17.6 km. However, our findings are con-
sistent with studies of particulate air pollution 
conducted in more heterogeneous populations.
Conclusions
We have used a pathway approach to investi-
gate how the processing of miRNAs may be a 
susceptibility factor for traffic particle–induced 
cardiovascular effects. Individual miRNAs may 
have multiple targets; more research is needed 
to address the relation between BC exposure 
and BP among diverse study populations and 
to clarify the mechanisms underlying the asso-
ciation between BC and BP. These results pro-
vide support for the hypothesis of the toxic 
effects of traffic pollution as measured by 
BC and contribute to growing understand-
ing about the role of epigenetic modification 
and response to environmental stresses such 
as exposure to BC. In cardiovascular research, 
these results may be used to explore inter-
actions with BC. Further investigations are 
needed to replicate our findings in other large 
cohort studies.
RefeRences
Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, 
Schwartz J. 2007. Ozone exposure and lung function: effect 
modified by obesity and airways hyperresponsiveness in 
the VA Normative Aging Study. Chest 132(6):1890–1897.
Asada S, Takahashi T, Isodono K, Adachi A, Imoto H, Ogata T, 
et al. 2008. Downregulation of Dicer expression by serum 
withdrawal sensitizes human endothelial cells to apoptosis. 
Am J Physiol Heart Circ Physiol 295(6):H2512–H2521.
Auchincloss AH, Roux AV, Dvonch JT, Brown PL, Barr RG, 
Daviglus ML, et al. 2008. Associations between recent 
exposure to ambient fine particulate matter and blood 
pressure in the multi-ethnic study of atherosclerosis 
(MESA). Environ Health Perspect 116:486–491.
Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, 
Suh HH, et al. 2009. Rapid DNA methylation changes after Wilker et al.
948  v o l u m e  118 | n u m b e r 7 | July 2010  •  Environmental Health Perspectives
exposure to traffic particles. Am J Respir Crit Care Med 
179(7):572–578.
Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mecha-
nism, and function. Cell 116(2):281–297.
Bartoli CR, Wellenius GA, Diaz EA, Lawrence J, Coull BA, 
Akiyama I, et al. 2009. Mechanisms of inhaled fine particu-
late air pollution-induced arterial blood pressure changes. 
Environ Health Perspect 117:361–366.
Bell B, Rose CL, Damon A. 1966. The Veterans Administration lon-
gitudinal study of healthy aging. Gerontologist 6(4):179–184.
Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, 
Li MZ, et al. 2003. Dicer is essential for mouse develop-
ment. Nat Genet 35(3):215–217.
Brewer AC, Shah AM. 2009. Redox signalling and miRNA func-
tion in cardiomyocytes. J Mol Cell Cardiol 47(1):2–4.
Brook RD. 2008. Cardiovascular effects of air pollution. Clin Sci 
(Lond) 115(6):175–187.
Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, 
et al. 1995. Prevalence of hypertension in the US adult pop-
ulation. Results from the Third National Health and Nutrition 
Examination Survey, 1988–1991. Hypertension 25(3):305–313.
Chahine T, Baccarelli A, Litonjua A, Wright RO, Suh H, Gold DR, 
et al. 2007. Particulate air pollution, oxidative stress genes, 
and heart rate variability in an elderly cohort. Environ 
Health Perspect 115:1617–1622.
Charroux B, Pellizzoni L, Perkinson RA, Yong J, Shevchenko A, 
Mann M, et al. 2000. Gemin4. A novel component of the 
SMN complex that is found in both gems and nucleoli. 
J Cell Biol 148(6):1177–1186.
Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, 
Deng Z, et al. 2008. Targeted deletion of dicer in the heart 
leads to dilated cardiomyopathy and heart failure. Proc 
Natl Acad Sci USA 105(6):2111–2116.
Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, et al. 2007. 
MicroRNAs are aberrantly expressed in hypertrophic 
heart: do they play a role in cardiac hypertrophy? Am J 
Pathol 170(6):1831–1840.
da Costa Martins PA, Bourajjaj M, Gladka M, Kortland M, van 
Oort RJ, Pinto YM, et al. 2008. Conditional Dicer gene dele-
tion in the postnatal myocardium provokes spontaneous 
cardiac remodeling. Circulation 118(15):1567–1576.
Divakaran V, Mann DL. 2008. The emerging role of microRNAs   
in cardiac remodeling and heart failure. Circ Res 
103(10):1072–1083.
Esquela-Kerscher A, Slack FJ. 2006. Oncomirs—microRNAs 
with a role in cancer. Nat Rev Cancer 6(4):259–269.
Fakhri AA, Ilic LM, Wellenius GA, Urch B, Silverman F, Gold DR, 
et al. 2009. Autonomic effects of controlled fine particulate 
exposure in young healthy adults: effect modification by 
ozone. Environ Health Perspect 117:1287–1292.
Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, 
Vasan RS, et al. 2009. Single versus combined blood pres-
sure components and risk for cardiovascular disease: The 
Framingham Heart Study. Circulation 119(2):243–250.
Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, 
et al. 2000. Ambient pollution and heart rate variability. 
Circulation 101(11):1267–1273.
Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. 
miRBase: Tools for microRNA genomics. Nucleic Acids 
Res 36(database issue):D154–D158.
Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, et al. 2006. 
Molecular basis for the recognition of primary microRNAs 
by the drosha-DGCR8 complex. Cell 125(5):887–901.
Harrabi I, Rondeau V, Dartigues JF, Tessier JF, Filleul L. 2006. 
Effects of particulate air pollution on systolic blood 
pressure: a population-based approach. Environ Res 
101(1):89–93.
Hernan MA, Lanoy E, Costagliola D, Robins JM. 2006. 
Comparison of dynamic treatment regimes via inverse 
probability weighting. Basic Clin Pharmacol Toxicol 
98(3):237–242.
Hoffmann B, Moebus S, Mohlenkamp S, Stang A, Lehmann N, 
Dragano N, et al. 2007. Residential exposure to traffic is 
associated with coronary atherosclerosis. Circulation 
116(5):489–496.
Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, et al. 2008. 
Single nucleotide polymorphisms of microRNA machinery 
genes modify the risk of renal cell carcinoma. Clin Cancer 
Res 14(23):7956–7962.
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, et al. 2008. Genetic 
variants of miRNA sequences and non-small cell lung 
cancer survival. J Clin Invest 118(7):2600–2608.
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, et al. 2009. 
Common genetic variants in pre-microRNAs were asso-
ciated with increased risk of breast cancer in Chinese 
women. Hum Mutat 30(1):79–84.
Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. 
2001. Effects of air pollution on blood pressure: a popula-
tion-based approach. Am J Public Health 91(4):571–577.
Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, et al. 
2007. Altered microRNA expression in human heart dis-
ease. Physiol Genomics 31(3):367–373.
Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. 
2009. Downregulation of microRNA expression in the lungs 
of rats exposed to cigarette smoke. FASEB J 23(3):806–812.
Jansen KL, Larson TV, Koenig JQ, Mar TF, Fields C, Stewart J, 
et al. 2005. Associations between health effects and par-
ticulate matter and black carbon in subjects with respira-
tory disease. Environ Health Perspect 113:1741–1746.
Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, 
et al. 2008. MicroRNA-196a targets annexin A1: a microR-
NA-mediated mechanism of annexin A1 downregulation in 
cancers. Oncogene 27(52):6667–6678.
Madrigano J, Baccarelli A, Wright R, Suh H, Sparrow D, 
Vokonas P, et al. 2009. Air pollution, obesity, genes, and 
cellular adhesion molecules. Occup Environ Med; doi: 
10.1136/oem.2009.046193 [Online 2 November 2009].
Madsen C, Nafstad P. 2006. Associations between environmen-
tal exposure and blood pressure among participants in the 
Oslo Health Study (HUBRO). Eur J Epidemiol 21(7):485–491.
Maniataki E, Mourelatos Z. 2005. A human, ATP-independent, 
RISC assembly machine fueled by pre-miRNA. Genes Dev 
19(24):2979–2990.
Mattick JS, Makunin IV. 2006. Non-coding RNA. Hum Mol 
Genet 15 Spec No 1:R17–R29.
Maynard D, Coull BA, Gryparis A, Schwartz J. 2007. Mortality 
risk associated with short-term exposure to traffic par-
ticles and sulfates. Environ Health Perspect 115:751–755.
Mordukhovich I, Wilker EH, Suh H, Wright RO, Sparrow D, 
Vokonas PS, et al. 2009. Black carbon exposure, oxidative 
stress genes, and blood pressure in a repeated measures 
study. Environ Health Perspect 117:1767–1772.
Murashov AK, Chintalgattu V, Islamov RR, Lever TE, Pak ES, 
Sierpinski PL, et al. 2007. RNAi pathway is functional in 
peripheral nerve axons. FASEB J 21(3):656–670.
O’Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, 
Economides PA, et al. 2005. Diabetes enhances vulner-
ability to particulate air pollution-associated impairment 
in vascular reactivity and endothelial function. Circulation 
111(22):2913–2920.
Park SK, O’Neill MS, Wright RO, Hu H, Vokonas PS, Sparrow D, 
et al. 2006. HFE genotype, particulate air pollution, and 
heart rate variability: a gene-environment interaction. 
Circulation 114(25):2798–2805.
Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, 
Krewski D, et al. 2004. Cardiovascular mortality and long-
term exposure to particulate air pollution: epidemiological 
evidence of general pathophysiological pathways of dis-
ease. Circulation 109(1):71–77.
Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, 
et al. 2009. Loss of cardiac microRNA-mediated regulation 
leads to dilated cardiomyopathy and heart failure. Circ Res 
105(6):585–594.
Ren C, Park SK, Vokonas PS, Sparrow D, Wilker E, Baccarelli A, 
et al. 2010. Air pollution and homocysteine: more evidence 
that oxidative stress-related genes modify effects of par-
ticulate air pollution. Epidemiology 21(2):198–206.
Rich DQ, Schwartz J, Mittleman MA, Link M, Luttmann-
Gibson H, Catalano PJ, et al. 2005. Association of short-
term ambient air pollution concentrations and ventricular 
arrhythmias. Am J Epidemiol 161(12):1123–1132.
Rocha S. 2007. Gene regulation under low oxygen: holding your 
breath for transcription. Trends Biochem Sci 32(8):389–397.
Rojas-Bracho L, Suh HH, Koutrakis P. 2000. Relationships 
among personal, indoor, and outdoor fine and coarse 
particle concentrations for individuals with COPD. J Expo 
Anal Environ Epidemiol 10(3):294–306.
Schwartz J, Litonjua A, Suh H, Verrier M, Zanobetti A, Syring M, 
et al. 2005. Traffic related pollution and heart rate variabil-
ity in a panel of elderly subjects. Thorax 60(6):455–461.
Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. 2007. 
Dicer dependent microRNAs regulate gene expres-
sion and functions in human endothelial cells. Circ Res 
100(8):1164–1173.
Suarez Y, Sessa WC. 2009. MicroRNAs as novel regulators of 
angiogenesis. Circ Res 104(4):442–454.
Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs 
in vascular diseases, inflammation, and angiogenesis. 
Cardiovasc Res 79(4):581–588.
van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, 
Olson EN. 2007. Control of stress-dependent cardiac 
growth and gene expression by a microRNA. Science 
316(5824):575–579.
Wan D, He M, Wang J, Qiu X, Zhou W, Luo Z, et al. 2004. Two 
variants of the human hepatocellular carcinoma-asso-
ciated HCAP1 gene and their effect on the growth of the 
human liver cancer cell line Hep3B. Genes Chromosomes 
Cancer 39(1):48–58.
Williams B, Lindholm LH, Sever P. 2008. Systolic pressure is all 
that matters. Lancet 371(9631):2219–2221.
Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X. 2008. 
Evaluation of genetic variants in microRNA-related genes 
and risk of bladder cancer. Cancer Res 68(7):2530–2537.
Yang W, Paschen W. 2008. Conditional gene silencing in mam-
malian cells mediated by a stress-inducible promoter. 
Biochem Biophys Res Commun 365(3):521–527.
Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. 
2005. Dicer is required for embryonic angiogenesis during 
mouse development. J Biol Chem 280(10):9330–9335.
Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-
Bengston E, et al. 2004. Ambient pollution and blood 
pressure in cardiac rehabilitation patients. Circulation 
110(15):2184–2189.
Zeger SL, Thomas D, Dominici F, Samet JM, Schwartz J, 
Dockery D, et al. 2000. Exposure measurement error in 
time-series studies of air pollution: concepts and conse-
quences. Environ Health Perspect 108:419–426.
Zhang C. 2008. MicroRNAs: role in cardiovascular biology and 
disease. Clin Sci (Lond) 114(12):699–706.